Imagen del autor
2 Obras 277 Miembros 14 Reseñas

Sobre El Autor

Katherine Eban, an investigative journalist, is a Fortune contributor and an Andrew Carnegie Fellow. She has also written for Vanity Fair, the New York Times, Self, The Nation, the New York Observer, and other publications. She is the author of Dangerous Doses: A True Story of Cops, Counterfeiters, mostrar más and the Contamination of America's Drug Supply, and lectures frequently on the topic of pharmaceutical integrity. Educated at Brown University and the University of Oxford, where she was a Rhodes Scholar, she lives in Brooklyn with her husband and two daughters. mostrar menos

Incluye el nombre: Katherine Eban

Créditos de la imagen: Katherine Eban

Obras de Katherine Eban

Etiquetado

Conocimiento común

Fecha de nacimiento
c. 1966
Género
female
Nacionalidad
USA
Lugares de residencia
Brooklyn, New York, USA
Educación
Brown University
University of East Anglia
University of Oxford (MPhil)
Ocupaciones
journalist

Miembros

Reseñas

5 stars

Bottle of Lies is the story of the generic drug boom of the early 2000s, specifically that caused by the increasing availability of cheap generic drugs from India and China. It follows the history of one specific Indian drug company, Ranbaxy, and the attempts by a whistleblower, certain contingents of the FDA, and FDA inspectors to bring attention to its widespread issues. In doing so, it exposes the consequences of globalization on the generic pharmaceutical industry as a whole.

This book was genuinely frightening. Eban's writing style is very engaging; it doesn't read like nonfiction. In fact, I spent most of the book wishing it was as I looked suspiciously at the pill bottle full of generic medication next to me. I would say it is one of the best pieces of investigative journalism I've ever read.
… (más)
 
Denunciada
abcace | 11 reseñas más. | Apr 2, 2024 |
Sobering look at the generic drug industry and the FDA that is supposed to be protecting us
 
Denunciada
corliss12000 | 11 reseñas más. | Mar 16, 2024 |
I did not finish this book because I found the language to be too "othering." The third strike was at 15% and I returned it to the library.
 
Denunciada
Greenfrog342 | 11 reseñas más. | Jan 22, 2024 |
This book is fairly limited in its scope, but it points out important issues that affect pretty much everyone because pretty much everyone, at one time or another, uses prescription medication. The main focus here is on a company in India and the government regulation of that company, but the issues raised go well beyond the "star attraction" of this book. There are "bad" people and bad companies and bad regulators and bad oversight of those regulators...and bad understanding by the average prescription drug buyer of how bad everything is. Many of us badly need to read this.… (más)
 
Denunciada
larryerick | 11 reseñas más. | Feb 11, 2023 |

Listas

Premios

También Puede Gustarte

Estadísticas

Obras
2
Miembros
277
Popularidad
#83,813
Valoración
4.1
Reseñas
14
ISBNs
15

Tablas y Gráficos